This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Taketoshi Okubu: Innovator in Heterocyclic Derivatives
Introduction
Taketoshi Okubu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic derivatives. His work focuses on compounds that have potential therapeutic applications.
Latest Patents
Taketoshi Okubu holds a patent for a tetrahydropyridino or piperidino heterocyclic derivative. This compound is represented by the formula [I]: A-Het [I] and exhibits a high affinity for CRF receptors. It is considered effective against diseases in which CRF is believed to play a role. This innovation highlights his commitment to advancing medical science.
Career Highlights
Throughout his career, Taketoshi Okubu has been associated with Taisho Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work has contributed to the development of new therapeutic agents that can improve patient outcomes.
Collaborations
Taketoshi has collaborated with notable colleagues, including Atsuro Nakazato and Toshihito Kumagai. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Taketoshi Okubu's contributions to the field of pharmaceuticals, particularly through his patent on heterocyclic derivatives, demonstrate his dedication to innovation and improving healthcare solutions. His work continues to inspire advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile